ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 63 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,174,370 | -27.8% | 255,298 | +1.4% | 0.00% | – |
| Q2 2023 | $1,625,814 | -90.1% | 251,674 | -88.4% | 0.00% | -100.0% |
| Q1 2023 | $16,403,631 | +78225.1% | 2,175,548 | +5.2% | 0.00% | -33.3% |
| Q4 2022 | $20,943 | -99.9% | 2,067,513 | +4.1% | 0.00% | 0.0% |
| Q3 2022 | $19,633,000 | -4.5% | 1,985,197 | +2.9% | 0.00% | 0.0% |
| Q2 2022 | $20,552,000 | +940.1% | 1,929,798 | +852.0% | 0.00% | – |
| Q1 2022 | $1,976,000 | -31.5% | 202,708 | +0.4% | 0.00% | – |
| Q4 2021 | $2,886,000 | +355.2% | 201,868 | +537.5% | 0.00% | – |
| Q3 2021 | $634,000 | -85.5% | 31,664 | -84.1% | 0.00% | -100.0% |
| Q2 2021 | $4,372,000 | -34.2% | 198,738 | +1.6% | 0.00% | 0.0% |
| Q1 2021 | $6,640,000 | -13.2% | 195,537 | +2.9% | 0.00% | 0.0% |
| Q4 2020 | $7,649,000 | – | 190,106 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |